XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.2
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash Flows from Operating Activities:    
Net (loss) income $ 10,160,000 $ (8,244,000)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 113,022,000 118,230,000
Straight-lining of rental revenue (4,001,000) (9,632,000)
Amortization of stock-based compensation expense 10,704,000 10,229,000
Loss from unconsolidated joint ventures 9,529,000 21,033,000
Amortization of deferred financing costs 3,077,000 4,640,000
Distributions of earnings from unconsolidated real estate funds 304,000 266,000
Distributions of earnings from unconsolidated joint ventures 34,000 623,000
Amortization of above and below-market leases, net (673,000) (1,613,000)
Income from unconsolidated real estate funds (325,000) (328,000)
Realized and unrealized gains on marketable securities   (1,480,000)
Other non-cash adjustments 560,000 868,000
Changes in operating assets and liabilities:    
Accounts and other receivables (2,206,000) 4,136,000
Deferred charges (5,097,000) (4,506,000)
Other assets 2,741,000 (5,569,000)
Accounts payable and accrued expenses (4,714,000) 3,698,000
Other liabilities (2,013,000) 2,107,000
Net cash provided by operating activities 131,102,000 134,458,000
Cash Flows from Investing Activities:    
Additions to real estate (54,136,000) (52,114,000)
Due from affiliates (51,916,000)  
Repayment of amounts due from affiliates 51,916,000  
Investments in and contributions of capital to unconsolidated joint ventures (11,252,000) (11,750,000)
Contributions of capital to unconsolidated real estate funds (4,219,000)  
Distributions of capital from unconsolidated real estate funds 1,506,000  
Purchases of marketable securities   (9,562,000)
Sales of marketable securities   11,381,000
Net cash used in investing activities (68,101,000) (62,045,000)
Cash Flows from Financing Activities:    
Dividends paid to common stockholders (32,307,000) (30,643,000)
Distributions paid to common unitholders (3,365,000) (3,042,000)
Distributions to noncontrolling interests (24,848,000) (8,562,000)
Contributions from noncontrolling interests   121,000
Repurchase of shares related to stock compensation agreements and related tax withholdings (280,000) (200,000)
Proceeds from notes and mortgages payable   12,430,000
Net cash used in financing activities (60,800,000) (29,896,000)
Net increase in cash and cash equivalents and restricted cash 2,201,000 42,517,000
Cash and cash equivalents and restricted cash at beginning of period 529,666,000 465,324,000
Cash and cash equivalents and restricted cash at end of period 531,867,000 507,841,000
Reconciliation of Cash and Cash Equivalents and Restricted Cash:    
Cash and cash equivalents at beginning of period 524,900,000 434,530,000
Restricted cash at beginning of period 4,766,000 30,794,000
Cash and cash equivalents and restricted cash at beginning of period 529,666,000 465,324,000
Cash and cash equivalents at end of period 506,933,000 475,289,000
Restricted cash at end of period 24,934,000 32,552,000
Cash and cash equivalents and restricted cash at end of period 531,867,000 507,841,000
Supplemental Disclosure of Cash Flow Information:    
Cash payments for interest 67,332,000 65,227,000
Cash payments for income taxes, net of refunds 1,941,000 210,000
Non-Cash Transactions:    
Common shares issued upon redemption of common units 107,212,000 165,000
Change in value of interest rate swaps and interest rate caps 24,654,000  
Dividends and distributions declared but not yet paid 18,787,000 16,897,000
Write-off of fully amortized and/or depreciated assets 8,617,000 37,149,000
Additions to real estate included in accounts payable and accrued expenses 7,212,000 $ 10,484,000
Transfer of deposit to investment in unconsolidated joint ventures $ 6,230,000